Follow
Stephen Ward
Stephen Ward
Professor of Pharmacology, University of Bath
Verified email at bath.ac.uk - Homepage
Title
Cited by
Cited by
Year
Chemokines and T lymphocytes: more than an attraction
SG Ward, K Bacon, J Westwick
Immunity 9 (1), 1-11, 1998
5681998
Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle
G Kolios, V Valatas, SG Ward
Immunology 113 (4), 427-437, 2004
5542004
Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial
CS Calfee, KL Delucchi, P Sinha, MA Matthay, J Hackett, M Shankar-Hari, ...
The Lancet Respiratory Medicine 6 (9), 691-698, 2018
5272018
Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing
K Wright, N Rooney, M Feeney, J Tate, D Robertson, M Welham, S Ward
Gastroenterology 129 (2), 437-453, 2005
4042005
The CXC chemokine stromal cell-derived factor activates a Gi-coupled phosphoinositide 3-kinase in T lymphocytes
Y Sotsios, GC Whittaker, J Westwick, SG Ward
The journal of Immunology 163 (11), 5954-5963, 1999
3291999
Chemokines: understanding their role in T-lymphocyte biology
SG WARD, J WESTWICK
Biochemical Journal 333 (3), 457-470, 1998
2961998
Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents
SG Ward, P Finan
Current opinion in pharmacology 3 (4), 426-434, 2003
2642003
The CC chemokine monocyte chemotactic peptide-1 activates both the class I p85/p110 phosphatidylinositol 3-kinase and the class II PI3K-C2α
SJ Turner, J Domin, MD Waterfield, SG Ward, J Westwick
Journal of Biological Chemistry 273 (40), 25987-25995, 1998
2331998
Chemokine signalling: pivoting around multiple phosphoinositide 3‐kinases
AP Curnock, MK Logan, SG Ward
Immunology 105 (2), 125-136, 2002
2202002
PI 3-kinase: a pivotal pathway in T-cell activation?
SG Ward, CH June, D Olive
Immunology today 17 (4), 187-197, 1996
2201996
CD28: a signalling perspective
SG Ward
Biochemical journal 318 (2), 361-377, 1996
2181996
RANTES-activated human T lymphocytes. A role for phosphoinositide 3-kinase.
L Turner, SG Ward, J Westwick
Journal of immunology (Baltimore, Md.: 1950) 155 (5), 2437-2444, 1995
2091995
Phosphoinositide 3-kinase: a key biochemical signal for cell migration in response to chemokines.
Y Sotsios, SG Ward
Immunological reviews 177, 217-235, 2000
2062000
Therapeutic potential of phosphoinositide 3-kinase inhibitors
S Ward, Y Sotsios, J Dowden, I Bruce, P Finan
Chemistry & biology 10 (3), 207-213, 2003
1952003
PI 3-K and T-cell activation: limitations of T-leukemic cell lines as signaling models
E Astoul, DA Cantrell, C Edmunds, SG Ward
Trends in immunology 22 (9), 490-496, 2001
1772001
Ligation of the T cell co‐stimulatory receptor CD28 activates the serine‐threonine protein kinase protein kinase B
RV Parry, K Reif, G Smith, DM Sansom, BA Hemmings, SG Ward
European journal of immunology 27 (10), 2495-2501, 1997
1621997
Evidence that SHIP-1 contributes to phosphatidylinositol 3, 4, 5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors
RW Freeburn, KL Wright, SJ Burgess, E Astoul, DA Cantrell, SG Ward
The Journal of Immunology 169 (10), 5441-5450, 2002
1602002
Ligation of CD28 receptor by B7 induces formation of D‐3 phosphoinositides in T lymphocytes independently of T cell receptor/CD3 activation
SG Ward, J Westwick, ND Hall, DM Sansom
European journal of immunology 23 (10), 2572-2577, 1993
1601993
Inhibition of PI3K Signaling Spurs New Therapeutic Opportunities in Inflammatory/Autoimmune Diseases and Hematological Malignancies.
FJGB Matthew D, CEW Stephen G.
Pharmacological Reviews 64 (4), 1027-54, 2012
1492012
Do phosphoinositide 3-kinases direct lymphocyte navigation?
SG Ward
Trends in immunology 25 (2), 67-74, 2004
1482004
The system can't perform the operation now. Try again later.
Articles 1–20